Start-ups continue to manage to tap venture capital funding despite the credit crunch with companies pulling down €52.1m from investors in the first three months of 2013.

THE most advanced in-trial drug of Dublin-headquartered bio-pharmaceutical company, Amarin is being tipped for “blockbuster” status, following successful Phase-3 trials.